Sarcopenia and Its Prognostic Role on Hospitalization and In-Hospital Mortality in Coronavirus Disease 2019 Patients

Mehmet Akif Erdöl1, Bircan Kayaaslan2, Mehmet Erdoğan1

  • 1Cardiology Unit, University of Health Sciences, Ankara City Hospital, Turkey.

Insights

Skeletal muscle measurements, including cross-sectional area and attenuation, can predict outcomes in patients hospitalized with coronavirus disease 2019 and cardiovascular risk factors. Lower muscle mass is associated with increased intensive care unit admission, mechanical ventilation, and mortality.

Area of Science:

  • Radiology and Imaging
  • Cardiovascular Medicine
  • Infectious Diseases

Background:

  • Coronavirus disease 2019 (COVID-19) is a global pandemic.
  • Patients with COVID-19 and cardiovascular risk factors face significant health challenges.
  • The prognostic role of skeletal muscle parameters in these patients requires further investigation.

Purpose of the Study:

  • To evaluate the prognostic significance of computed tomography (CT)-based skeletal muscle measurements in hospitalized COVID-19 patients with cardiovascular risk factors.
  • To assess the relationship between muscle cross-sectional area, index, and attenuation and clinical outcomes.

Main Methods:

  • Retrospective analysis of 232 COVID-19 patients with at least one cardiovascular risk factor.
  • Automated measurement of erector spinae, pectoralis, and total skeletal muscle (SM) parameters on CT scans.
  • Stratification of patients into tertiles based on total SM cross-sectional area (SMcsa) index and correlation with clinical outcomes.

Main Results:

  • Higher rates of intensive care unit admission, mechanical ventilation, and mortality were observed in the lowest muscle mass tertile (tertile 3).
  • Significantly lower muscle measurements were found in tertile 3 (P < .001).
  • Diabetes mellitus, hypertension, and low total SMcsa index were independent predictors of in-hospital mortality.

Conclusions:

  • Sarcopenia, assessed by CT-based muscle measurements, can predict disease severity and outcomes in COVID-19 patients.
  • Skeletal muscle parameters are valuable prognostic indicators in COVID-19 patients with cardiovascular comorbidities.
  • Early identification of sarcopenia may aid in risk stratification and management of COVID-19 patients.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
75
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
99
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
51
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
61
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
648
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
81